CORD-19:775b90287b44353bee979abb0970a4666022f86d / 96316-96476 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"To assess the severity of the disease and impact on QoL, patients responded to Visual Analogue Scale (VAS) and Sinonasal Outcome Test 22 (SNOT-22) respectively.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T79847","span":{"begin":0,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T79847","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T456","span":{"begin":0,"end":160},"obj":"Sentence"}],"attributes":[{"subj":"T456","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T151","span":{"begin":95,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A151","pred":"uberon_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"},{"subj":"T151","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecd493","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ba93ec"},{"id":"CORD-19-PD-UBERON","color":"#93eca0"}]}]}}